Literature DB >> 22012612

Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats.

Felipe Schmitz1, Emilene Barros da Silva Scherer, Maira Jaqueline da Cunha, Aline Andrea da Cunha, Daniela Delwing Lima, Débora Delwing, Carlos Alexandre Netto, Angela Terezinha de Souza Wyse.   

Abstract

Methylphenidate (MPH), a psychostimulant that affects both dopaminergic and noradrenergic systems, is one of the most frequently prescribed treatments for attention-deficit hyperactivity disorder. The present study investigated the effects of chronic administration of MPH on some parameters of oxidative stress, as well as on butyrylcholinesterase (BuChE) activity in blood of young rats. Rats received intraperitoneal injections of MPH (2.0 mg/kg) once a day, from the 15th to the 45th day of age or an equivalent volume of 0.9% saline solution (controls). Two hours after the last injection, animals were euthanized, and blood was collected. Results demonstrated that MPH did not alter the dichlorofluorescein formed, decreased both thiobarbituric acid reactive substances and total non-enzymatic radical-trapping antioxidant, and increased superoxide dismutase and catalase activities, suggesting that this psychostimulant may alter antioxidant defenses. BuChE activity was increased in blood of juvenile rats subjected to chronic MPH administration. These findings suggest that MPH may promote peripheral oxidative adaptations and cholinergic changes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012612     DOI: 10.1007/s11010-011-1113-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  50 in total

1.  Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children.

Authors:  D J Safer; R P Allen
Journal:  J Pediatr       Date:  1989-12       Impact factor: 4.406

2.  Butyrylcholinesterase activity and risk factors for coronary artery disease.

Authors:  V M Alcântara; E A Chautard-Freire-Maia; M Scartezini; M S J Cerci; K Braun-Prado; G Picheth
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

3.  Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.

Authors:  Francieli M Stefanello; Renata Franzon; Bárbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

4.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

5.  Organometal-induced increases in oxygen reactive species: the potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage.

Authors:  C P LeBel; S F Ali; M McKee; S C Bondy
Journal:  Toxicol Appl Pharmacol       Date:  1990-06-01       Impact factor: 4.219

6.  Butyrylcholinesterase in metabolic syndrome.

Authors:  Gumpeny R Sridhar; Allam Appa Rao; Kudipudi Srinivas; Gumpeny Nirmala; Gumpeny Lakshmi; Dasika Suryanarayna; Padmanabhuni V Nageswara Rao; Dowluru G S V G L Kaladhar; Sali Veeresh Kumar; Tatavarthi Uma Devi; Turaga Nitesh; Thota Hanuman
Journal:  Med Hypotheses       Date:  2010-08-24       Impact factor: 1.538

Review 7.  Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.

Authors:  E J Garland
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

8.  Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.

Authors:  R T Brown; M E Wynne; L W Slimmer
Journal:  J Clin Psychiatry       Date:  1984-11       Impact factor: 4.384

9.  Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats.

Authors:  Karin M Gomes; Cecília G Inácio; Samira S Valvassori; Gislaine Z Réus; Carina R Boeck; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurosci Lett       Date:  2009-08-27       Impact factor: 3.046

10.  24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.

Authors:  Cindy D Stowe; Stephanie F Gardner; Charles C Gist; Eldon G Schulz; Thomas G Wells
Journal:  Ann Pharmacother       Date:  2002 Jul-Aug       Impact factor: 3.154

View more
  11 in total

1.  Chronic Treatment with a Clinically Relevant Dose of Methylphenidate Increases Glutamate Levels in Cerebrospinal Fluid and Impairs Glutamatergic Homeostasis in Prefrontal Cortex of Juvenile Rats.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Daniella M Coelho; Ben Hur Mussulini; Mery S L Pereira; Mariana M Parisi; Florencia Barbé-Tuana; Diogo L de Oliveira; Carmen R Vargas; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2015-05-24       Impact factor: 5.590

2.  Methylphenidate Causes Behavioral Impairments and Neuron and Astrocyte Loss in the Hippocampus of Juvenile Rats.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Matheus Grunevald; Letícia F Pettenuzzo; Giselli Scaini; Emilio L Streck; Carlos A Netto; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.590

3.  Does methylphenidate use affect sperm parameters in patients undergoing infertility investigation? A retrospective analysis of 9769 semen samples.

Authors:  Hadar Shalev; Yuval Mizrakli; Iris Har-Vardi; Eliahu Levitas; Atif Zeadna; Avi Harlev; Etan Levitas; Gal Ifergane; Eitan Lunenfeld; Victor Novack
Journal:  Arch Gynecol Obstet       Date:  2021-01-12       Impact factor: 2.344

4.  Methylphenidate Decreases ATP Levels and Impairs Glutamate Uptake and Na+,K+-ATPase Activity in Juvenile Rat Hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

5.  Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; Helena Biasibetti-Brendler; Fernanda Silva Ferreira; Fernanda Dos Santos Petry; Vera Maria Treis Trindade; Regina Pessoa-Pureur; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2017-12-29       Impact factor: 3.584

6.  Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks.

Authors:  Felipe Schmitz; Josiane S Silveira; Gianina T Venturin; Samuel Greggio; Guilherme Schu; Eduardo R Zimmer; Jaderson Costa Da Costa; Angela T S Wyse
Journal:  Neurotox Res       Date:  2021-11-19       Impact factor: 3.911

7.  Methylphenidate treatment leads to abnormalities on krebs cycle enzymes in the brain of young and adult rats.

Authors:  Gislaine Z Réus; Giselli Scaini; Camila B Furlanetto; Meline O S Morais; Isabela C Jeremias; Lis Mairá Mello-Santos; Karolina V Freitas; João Quevedo; Emilio L Streck
Journal:  Neurotox Res       Date:  2013-02-20       Impact factor: 3.911

8.  Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats.

Authors:  Felipe Schmitz; Emilene B S Scherer; Fernanda R Machado; Aline A da Cunha; Bárbara Tagliari; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-09-12       Impact factor: 3.584

9.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

10.  Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).

Authors:  Ike dela Peña; Hee Jin Kim; Aeree Sohn; Bung-Nyun Kim; Doug Hyun Han; Jong Hoon Ryu; Chan Young Shin; Minsoo Noh; Jae Hoon Cheong
Journal:  Behav Brain Funct       Date:  2014-05-06       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.